These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 26458959)
1. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control. Ting F; Tran M; Böhm M; Siriwardana A; Van Leeuwen PJ; Haynes AM; Delprado W; Shnier R; Stricker PD Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):46-52. PubMed ID: 26458959 [TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer. Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167 [TBL] [Abstract][Full Text] [Related]
3. Focal irreversible electroporation as primary treatment for localized prostate cancer. van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935 [TBL] [Abstract][Full Text] [Related]
4. Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation. Scheltema MJ; Chang JI; van den Bos W; Böhm M; Delprado W; Gielchinsky I; de Reijke TM; de la Rosette JJ; Siriwardana AR; Shnier R; Stricker PD Eur Urol Focus; 2019 Jul; 5(4):585-591. PubMed ID: 29102671 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments. Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263 [TBL] [Abstract][Full Text] [Related]
6. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. Scheltema MJ; van den Bos W; de Bruin DM; Wijkstra H; Laguna MP; de Reijke TM; de la Rosette JJ BMC Cancer; 2016 May; 16():299. PubMed ID: 27150293 [TBL] [Abstract][Full Text] [Related]
7. Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort. Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P Eur Urol Oncol; 2020 Jun; 3(3):283-290. PubMed ID: 31103721 [TBL] [Abstract][Full Text] [Related]
9. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551 [TBL] [Abstract][Full Text] [Related]
10. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Valerio M; Stricker PD; Ahmed HU; Dickinson L; Ponsky L; Shnier R; Allen C; Emberton M Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):343-7. PubMed ID: 25179590 [TBL] [Abstract][Full Text] [Related]